Results 41 to 50 of about 867,691 (306)

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Unraveling the effects of DIP payment reform on inpatient healthcare: insights into impacts and challenges

BMC Health Services Research
Background The Diagnosis-Intervention Packet (DIP) payment system, initiated by China's National Healthcare Security Administration, is designed to enhance healthcare efficiency and manage rising healthcare costs.
Ying Zhang, Shu-yi Xu, Guang-ming Tan
doaj   +1 more source

Prediction and the influencing factor study of colorectal cancer hospitalization costs in China based on machine learning-random forest and support vector regression: a retrospective study

Frontiers in Public Health
AimsAs people’s standard of living improves, the incidence of colorectal cancer is increasing, and colorectal cancer hospitalization costs are relatively high.
Jun Gao, Jun Gao, Yan Liu
doaj   +1 more source

PELATIHAN SISTEM INFORMASI REKAM MEDIS DI PUSKESMAS PEMBANTU PEJUKUTAN, NUSA PENIDA BALI

Dharma Raflesia, 2020
Pejukutan village is one of the villages in Nusa Penida sub-district, Klungkung regency, Bali province. In the health sector in this village there is a Helper Health Center.
nyoman purnama, A. A. Istri Ita Paramitha   +1 more
doaj   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Comparative Study of Structure and Activity of Health Information Management Association in Selected Countries, 2008

مدیریت اطلاعات سلامت, 2010
Introduction: Formation of professional associations is one point of inflection in the health care industry. Health Information Management Association in developed countries originally initiated its activities in the profession of medical records as ...
Javad Monzavi Barzoki, Ahmadreza Raeisi, Sakineh Saghaeiannejad Isfahani, Nahid Tavakoli   +3 more
doaj  

Health record systems that meet clinical needs

Italian Journal of Medicine, 2012
Introduction Increased attention has recently been focused on health record systems as a result of accreditation programs, a growing emphasis on patient safety, and the increase in lawsuits involving allegations of malpractice. Health-care professionals
Gabriella Negrini
doaj   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

ارزیابی کمی پرونده‌های پزشکی بیماران بستری شده

مدیریت اطلاعات سلامت, 2011
مقدمه: امکان بررسی کمیت پرونده‌های پزشکی یکی از عوامل تأثیرگذار در سیاست‌های بیمارستانی، ارزیابی عملکرد کادر درمان و بهبود فعالیت‌های اجرایی می‌باشد و به عنوان اولین وسیله جهت ارزیابی کیفیت مراقبت ارایه شده توسط مؤسسات مراقبتی به حساب می‌آید و با وجود ...
Shirin Abbassi, Nahid Tavakoli
doaj